Center for Biomedical Materials and Tissue Engineering, Academy for Advanced Interdisciplinary Studies, Peking University, Haidian District Chengfu Road No.205, Beijing 100871, China.
Department of Orthopedic Surgery, Beijing Jishuitan Hospital, Fourth Clinical College of Peking University, No. 31 Xinjiekou East Street, Xicheng District, Beijing 100035, China.
Acta Biomater. 2020 Sep 1;113:196-209. doi: 10.1016/j.actbio.2020.06.017. Epub 2020 Jun 17.
Considering the intrinsic poor self-healing capacity of meniscus, tissue engineering has become a new direction for the treatment of meniscus lesions. However, disturbed by mechanical stability and biocompatibility, most meniscus implants fail to relieve symptoms and prevent the development of osteoarthritis. The goal of this study was to develop a potential meniscal substitute for clinical application. Here, silk fibroin with good mechanical performance and biocompatibility, and strontium ion acting as bioactive factor, were incorporated with Ɛ-Polycaprolactone to fabricate a meniscus scaffold (SP-Sr). By the wet-electrospun method, the 3D SP-Sr provided suitable pore size (100-200 μm) and enough mechanical support (61.6 ± 2.9 MPa for tensile modulus and 0.11 ± 0.03 MPa for compressive modulus). Moreover, after addition of Sr, the SP-Sr seeded by rabbit adipose tissue-derived stromal cells (rADSCs) showed the highest secretion with 2.61- and 2.98-fold increase in collagen and aggrecan, respectively, compared with SF/PCL group. And the extracellular matrix related genes expression in SP-Sr also showed upregulation results. Particularly, the expression of the collagen II gene, which played a crucial role in the formation of meniscal inner avascular region, showed a 9-fold increase in SP-Sr compared with pure PCL group. Furthermore, the MRI results of SP-Sr implanted in rabbits with total meniscectomy for 6 months demonstrated effective prevention of meniscus extrusion and relieving joint space narrowing compared with meniscectomy group. And the effects of cartilage protection and delaying osteoarthritis development were confirmed by Pathological examination. Especially, after 6-month implantation, the neo-menisci showed similar structural constituent and mechanical performance. STATEMENT OF SIGNIFICANCE: Meniscus regeneration faces great challenge due to the meniscus having limited healing potential owing to its anisotropic structure, its hypocellularity and hypovascularity. The present tissue engineering solutions have failed to maintain the biological function for meniscus reconstruction in vivo because of fragile and poor biocompatible materials, leading to long-term joint degeneration. The goal of this study was to develop a meniscal substitute potential for clinical application. Here, silk fibroin and strontium were incorporated with Ɛ-Polycaprolactone by wet-electrospinning method to fabricate a meniscus scaffold (SP-Sr). The 6-month implantation results revealed that SP-Sr scaffold was effective in preventing meniscus extrusion, cartilage protection and delaying osteoarthritis development, and the regenerated menisci showed similar structural constituent and mechanical performance.
考虑到半月板自身愈合能力差,组织工程已成为治疗半月板损伤的新方向。然而,由于机械稳定性和生物相容性差,大多数半月板植入物未能缓解症状并防止骨关节炎的发展。本研究的目的是开发一种有潜力的半月板替代品,用于临床应用。在这里,具有良好机械性能和生物相容性的丝素蛋白和作为生物活性因子的锶离子与聚己内酯共混,制备了半月板支架(SP-Sr)。通过湿法静电纺丝法,3D SP-Sr 提供了合适的孔径(100-200μm)和足够的机械支撑(拉伸模量为 61.6±2.9MPa,压缩模量为 0.11±0.03MPa)。此外,添加 Sr 后,兔脂肪组织来源基质细胞(rADSCs)接种的 SP-Sr 胶原蛋白和聚集蛋白的分泌量分别增加了 2.61 倍和 2.98 倍,与 SF/PCL 组相比。并且 SP-Sr 中的细胞外基质相关基因表达也呈现上调结果。特别是,在半月板内无血管区形成中起关键作用的胶原 II 基因的表达在 SP-Sr 中增加了 9 倍,与纯 PCL 组相比。此外,在半月板全切的兔中植入 SP-Sr 6 个月的 MRI 结果表明,与半月板切除组相比,SP-Sr 可有效防止半月板挤出并缓解关节间隙变窄。组织学检查证实了对软骨的保护和对骨关节炎发展的延缓作用。特别是,植入 6 个月后,新形成的半月板表现出相似的结构成分和机械性能。意义声明:由于半月板的各向异性结构、低细胞密度和低血管密度,半月板的愈合潜力有限,因此半月板再生面临巨大挑战。目前的组织工程解决方案由于脆弱和生物相容性差的材料,未能在体内维持半月板重建的生物学功能,导致长期关节退化。本研究的目的是开发一种有潜力的半月板替代品,用于临床应用。在这里,丝素蛋白和锶通过湿法静电纺丝法与聚己内酯共混,制备了半月板支架(SP-Sr)。6 个月的植入结果表明,SP-Sr 支架能有效防止半月板挤出、保护软骨并延缓骨关节炎的发展,再生的半月板具有相似的结构成分和机械性能。